Home / Event / FDA Approves Mavyret for Hepatitis C

FDA Approves Mavyret for Hepatitis C

Hepatitis C is a viral liver infection spread through blood that affects an estimated 3.5 million people in the United States. It can take years to see the effects of the disease. Mavyret is the first drug to be approved by the Food and Drug Administration that can cure all six genetic types of Hepatitis C in about two months. Other approved drugs generally require 12 weeks to treat the disease and often aren’t effective for all types of Hepatitis C. For more information click here.